In connection with the implementation of the project entitled ‘Design and development of nanoparticle-RNA based drugs to be used in anti-cancer therapy with the construction of a nanoparticle platform for targeted delivery of therapeutic nucleic acids’ by BS Biotechna SA, under agreement no. 2022/ABM/06/00005-00 for co-financing of a commercial project as part of the Competition for the development of
targeted or personalised medicine based on medicinal products based on nucleic acids and small molecule compounds, the Ordering Party is conducting market research on the costs of purchasing a scanner enabling non-invasive 3D measurement of xenograft tumours in mice – full 3D visualisation of the tumour with dedicated software for analysing measurements and a laptop.
In order to submit an offer, please read the detailed content of the announcement posted in the market research 81/2024 and send the completed offer form.